A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4

Journal of Materials Science: Materials in Medicine

Volumn 22, Issue 6, 2011, Pages 1521-1528

  Sinn, Stefan ^a   Scheuermann, Torsten ^b   Deichelbohrer, Stephan ^a   Ziemer, Gerhard ^a   Wendel, Hans P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Boston Scientific Technologie Zentrum GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHANDLER-LOOP MODEL; CORONARY ARTERIES; CORONARY ARTERY STENT; HEMOCOMPATIBILITY; IN-VITRO; INTRAVASCULAR STENTS; PLATELET ACTIVATION; PRE-CLINICAL TESTING; STATISTICALLY SIGNIFICANT DIFFERENCE; STENT IMPLANTATION; THERMOSTATED WATER; THROMBOGENICITY; WHOLE BLOOD;

BLOOD; COAGULATION;

SURFACE TESTING;

HEPARIN;

ANTICOAGULATION; ARTICLE; BARE METAL STENT; BLOOD CLOTTING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTRAVASCULAR STENT; MALE; MATERIAL COATING; NORMAL HUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION; THROMBOGENESIS; THROMBOSIS;

ANTICOAGULANTS; BLOOD CELL COUNT; BLOOD CELLS; BLOOD COAGULATION; BLOOD PLATELETS; BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; HEPARIN; HUMANS; INFLAMMATION; MALE; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; PLATELET ACTIVATION; REFERENCE STANDARDS; STENTS;

ANIMALIA;

EID: 80051593887     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4335-2     Document Type: Article

References (26)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701-6. (Pubitemid 17036474)
2. Thierry B, Merhi Y, Bilodeau L, Trepanier C, Tabrizian M. Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model. Biomaterials. 2002;23(14):2997-3005. (Pubitemid 34498321)
3. Mrowietz C, Franke RP, Seyfert UT, Park JW, Jung F. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents. Clin Hemorheol Microcirc. 2005;32(2):89-103. (Pubitemid 40529070)
4. Arab D, Lewis B, Cho L, Steen L, Joyal D, Leya F. Antiplatelet therapy in anticoagulated patients requiring coronary intervention. J Invasive Cardiol. 2005;17(10):549-54.
5. Romano A, Jensen MR, McAlpine J. Toward the optimization of stent-based treatment for coronary artery disease. Curr Opin Drug Discov Devel. 2010;13(2):157-8.
6. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, et al. Angiographic follow-up after placement of a selfexpanding coronary-artery stent. N Engl J Med. 1991;324(1):13-7.
7. Serruys PW, Di MC. Who was thrombogenic: the stent or the doctor? Circulation. 1995;91(6):1891-3.
8. Tamberella MR, Furman MI. The role of platelet inhibition in the drug-eluting stent era. Coron Artery Dis. 2004;15(6):327-9. (Pubitemid 39299247)
9. Palmaz JC. The 2001 Charles T. Dotter lecture: understanding vascular devices at the molecular level is the key to progress. J Vasc Interv Radiol. 2001;12(7):789-94. (Pubitemid 32642428)
10. Palmaz JC. Bring that pioneering spirit back! A 25-year perspective on the vascular stent. Cardiovasc Intervent Radiol. 2007;30(6):1095-8. (Pubitemid 350059836)
11. Davis C, Fischer J, Ley K, Sarembock IJ. The role of inflammation in vascular injury and repair. J Thromb Haemost. 2003;1(8):1699-709.
12. Chandler AB. In vitro thrombotic coagulation of the blood; a method for producing a thrombus. Lab Invest. 1958;7(2):110-4.
13. Song W, Lee J, Kim H, Shin J, Oh D, Tio F, et al. A new percutaneous porcine coronary model of chronic total occlusion. J Invasive Cardiol. 2005;17(9):452-4.
14. Tanigawa N, Sawada S, Kobayashi M. Reaction of the aortic wall to six metallic stent materials. Acad Radiol. 1995;2(5):379-84.
15. Kaminska M, Okroj W, Szymanski W, Jakubowski W, Komorowski P, Nosal A, et al. Interaction of parylene C with biological objects. Acta Bioeng Biomech. 2009;11(3):19-25.
16. Seyfert UT, Perkins S, Kummel M. Hemocompatibility testing of polymers. Beitr Infusionsther Transfusionsmed. 1996;33:241-6.
17. Seyfert UT, Biehl V, Schenk J. In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Biomol Eng. 2002;19(2-6):91-6.
18. Szapary L, Bagoly E, Kover F, Feher G, Pozsgai E, Koltai K, et al. The effect of carotid stenting on rheological parameters, free radical production and platelet aggregation. Clin Hemorheol Microcirc. 2009;43(3):209-17.
19. Gupta V, Aravamuthan BR, Baskerville S, Smith SK, Gupta V, Lauer MA, et al. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry. J Invasive Cardiol. 2004;16(6):304-10. (Pubitemid 38715811)
20. Beythien C, Gutensohn K, Bau J, Hamm CW, Kuhnl P, Meinertz T, et al. Influence of stent length and heparin coating on platelet activation: a flow cytometric analysis in a pulsed floating model. Thromb Res. 1999;94(2):79-86. (Pubitemid 29197374)
21. Gemmell CH. Activation of platelets by in vitro whole blood contact with materials: increases in microparticle, procoagulant activity, and soluble P-selectin blood levels. J Biomater Sci Polym Ed. 2001;12(8):933-43. (Pubitemid 33040009)
22. Inoue T, Hikichi Y, Morooka T, Yoshida K, Fujimatsu D, Komoda H, et al. Comparison of changes in circulating plateletderived microparticles and platelet surface P-selectin expression after coronary stent implantation. Platelets. 2006;17(6):416-20. (Pubitemid 44410506)
23. Tylman M, Bengtson JP, Bengtsson A. Activation of the complement system by different autologous transfusion devices: an in vitro study. Transfusion. 2003;43(3):395-9. (Pubitemid 36351133)
24. Beythien C, Terres W, Hamm CW. In vitro model to test the thrombogenicity of coronary stents. Thromb Res. 1994;75(6):581-90. (Pubitemid 24292008)
25. Hong J, Nilsson EK, Reynolds H, Larsson R, Nilsson B. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin. Biomaterials. 1999;20(7):603-11. (Pubitemid 29126730)
26. Tu Q, Zhao Y, Xue X, Wang J, Huang N (2010) Improved endothelialization of titanium vascular implants by extracellular matrix secreted from endothelial cells. Tissue Eng A. 16(12):3635-45.